Juvenile Dermatomyositis
NCT03433638 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 22
Last updated 2018-02-27
Summary
This is a retrospective descriptive cross-sectional and observational multicenter clinical and progressive study of juvenile dermatomyositis. The aim is to determine the clinical, paraclinical, and evolutive characteristics and therapeutic modalities from a series of juvenile dermatomyositis identified in Alsace between 2000 to 2015.
Conditions
- Juvenile Dermatomyositis
Sponsors & Collaborators
-
University Hospital, Strasbourg, France
lead OTHER
Eligibility
- Min Age
- 1 Day
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-02-08
- Primary Completion
- 2019-01-31
- Completion
- 2019-01-31
Countries
- France
Study Locations
More Related Trials
-
Optical Coherence Tomography Imaging in Systemic Sclerosis
NCT04532151 ·Status: COMPLETED ·Phase: NA
-
Observational Study of a Cohort of Patients With Hereditary Epidermolysis Bullosa
NCT04217538 ·Status: COMPLETED
-
Cutaneous and Mucosal Manifestations of Neurofribromatosis Type 2 in Children Under 15
NCT03893643 ·Status: UNKNOWN
-
Lenalidomide in the Treatment of Refractory Cutaneous Dermatomyositis
NCT05488327 ·Status: UNKNOWN ·Phase: NA
-
Study and Treatment of Inflammatory Muscle Diseases
NCT00001265 ·Status: COMPLETED
-
Prevalence and Subjective Impairment of Quality of Life (QoL) Due to Dermatologic Diseases in Internal Medicine Patients
NCT01044043 ·Status: COMPLETED
-
Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)
NCT02945345 ·Status: RECRUITING
-
Analysis of Cytokine Expression Pattern in Systemic Sclerosis
NCT03537105 ·Status: COMPLETED ·Phase: NA
-
Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Controls
NCT00213525 ·Status: COMPLETED
-
Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
NCT05732987 ·Status: RECRUITING
-
Clinical Research on Advanced Warning Factors Of Respiratory Injury in Dermatomyositis
NCT04747652 ·Status: UNKNOWN
-
Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.
NCT01743612 ·Status: COMPLETED ·Phase: NA
-
Role of Eosinophil in Fibrogenesis of Systemic Sclerosis
NCT03816189 ·Status: COMPLETED
-
Evaluation of Calcinosis in Systemic Sclerosis
NCT03340194 ·Status: COMPLETED
-
The Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis Patients
NCT04966884 ·Status: UNKNOWN ·Phase: PHASE4
-
Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.
NCT03559465 ·Status: COMPLETED ·Phase: NA
-
SARCOTHAL. Thalidomide in Skin Sarcoidosis
NCT00305552 ·Status: COMPLETED ·Phase: PHASE3
-
Exploring Patient Reported Outcomes in Inherited Ichthyosis
NCT06123091 ·Status: RECRUITING
-
Effect of Anti CD20 in Pemphigus Desease
NCT00213512 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Dermatologic Patterns of Tuberous Sclerosis Patients and Somatic Mutation Relationship
NCT04112537 ·Status: UNKNOWN
-
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
NCT07021495 ·Status: RECRUITING
-
Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study
NCT03582800 ·Status: RECRUITING ·Phase: PHASE2
-
Prevalence of Onychodystrophy in Patients With Chronic Venous Disease of the Lower Limbs
NCT02731222 ·Status: COMPLETED
-
What is the Optimal Follow-up for Patients With Systemic Sclerosis?
NCT05103553 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Alteration of Dermal Elastic Fibers During Calcifying Dermatosis: Structural Study Using Multiphoton Microscopy
NCT05112744 ·Status: UNKNOWN